Cargando…
Influence of cyclin D1 splicing variants expression on breast cancer chemoresistance via CDK4/CyclinD1‐pRB‐E2F1 pathway
Cyclin D1 (CCND1), a mediator of cell cycle control, has a G870A polymorphism which results in the formation of two splicing variants: full‐length CCND1 (CCND1a) and C‐terminally truncated CCND1 species (CCND1b). However, the role of CCND1a and CCND1b variants in cancer chemoresistance remains unkno...
Autores principales: | Wang, Jing, Zhang, Jiaxin, Ma, Qinglong, Zhang, Shasha, Ma, Fengdie, Su, Wei, Zhang, Taotao, Xie, Xiaodong, Di, Cuixia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064037/ https://www.ncbi.nlm.nih.gov/pubmed/36915230 http://dx.doi.org/10.1111/jcmm.17716 |
Ejemplares similares
-
Aberrant Cyclin D1 splicing in cancer: from molecular mechanism to therapeutic modulation
por: Wang, Jing, et al.
Publicado: (2023) -
Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas.
por: Maelandsmo, G. M., et al.
Publicado: (1996) -
CyclinD1, a prominent prognostic marker for endometrial diseases
por: Liang, Shuo, et al.
Publicado: (2013) -
The role of p16-cyclin D/CDK-pRb pathway in the tumorigenesis of endometrioid-type endometrial carcinoma
por: Tsuda, H, et al.
Publicado: (2000) -
Cul4B promotes the progression of ovarian cancer by upregulating the expression of CDK2 and CyclinD1
por: Duan, Peng-jing, et al.
Publicado: (2020)